Tradestie Institutional Equity Comparison Engine

FATE vs VCYT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while FATE counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, FATE trades at N/M Forward P/E with -2736.9% operating margin (+9.2% YoY revenue) versus VCYT at 15.3x Forward P/E and 15.0% operating margin (+15.1% YoY). In options structure, FATE sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro) against VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
FATE N/M vs VCYT 15.3x Fwd P/E
Growth & Margin Winner VCYT
Op Margin -2736.9% vs 15.0% ยท YoY +9.2% vs +15.1%
Momentum & Technical Winner FATE
1Y +14.9% vs -39.8% ยท 52W Pos 8% vs 5%
Options & Structure Winner FATE
BREAKDOWN (20th %ile IV) vs BREAKDOWN (47th %ile IV)
FATE NASDAQ
Fate Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$1.14
-10.94% 1D
Market Cap $155.7M
1M Return -36.31%
1Y Return +14.88%
Forward P/E N/M
Unified AI Score
43.0 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 67.0 Mom 55.0
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FATE +14.88% VCYT -39.78% Spread: +54.66 pp (FATE Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period FATE Revenue VCYT Revenue FATE Op. Margin VCYT Op. Margin Margin Edge
FY2018 $0M $90M -1415.4% -24.2% VCYT
FY2019 $10M $120M -943.1% -12.6% VCYT
FY2020 $30M $120M -407.5% -30.1% VCYT
FY2021 $60M $220M -388.6% -37.3% VCYT
FY2022 $100M $300M -320.2% -13.9% VCYT
FY2023 $60M $360M -299.9% -23.8% VCYT
FY2024 $10M $450M -1542.6% 3.6% VCYT
FY2025 $10M $520M -2222.4% 11.2% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FATE (2) vs VCYT (8)
Institutional Metric FATE VCYT Criterion Row Winner
Market Capitalization Scale $155.7M $2.0B Larger Scale VCYT
Trailing P/E Ratio Valuation N/M 15.8x Lower Multiple VCYT
Forward P/E Ratio Valuation N/M 15.3x Lower Multiple VCYT
Revenue Growth (YoY) Growth +9.2% +15.1% Higher Growth VCYT
Operating Margin (TTM) Profitability -2736.9% 15.0% Higher Margin VCYT
Net Profit Margin Profitability 0.0% 21.8% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency -67.8% 9.4% Higher ROE VCYT
52-Week Range Position Momentum 8% ($1โ€“$3) 5% ($22โ€“$61) Stronger Trend FATE
Beta / 30D Volatility Risk Regime 2.16ฮฒ ยท 104% Vol 3.01ฮฒ ยท 199% Vol Lower Realized Risk FATE
Unified Institutional Score Composite Signal 43.0 / 100 (HOLD) 49.1 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FATE vs VCYT Buy Guide
FATE BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live FATE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FATE nor VCYT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.